CCM — Stock Film
STOCK FILMSCENE 1/11CCM · $3.97
Stock Expert AI presents
CCM
Concord Medical Services Holdings Limited
~5 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
Concord Medical Services Holdings Limited. What it actually does.

Operates a network of radiotherapy and diagnostic imaging centers in China. Provides linear accelerator external beam radiotherapy. Now — the numbers.

on the stock market since 2009
610 employees
$578K market value
WHERE DOES THE MONEY COME FROM?
81%Services and other revenues
Services and other revenuesMedicine income 17%Equipment Leasing Revenues 2%
81% of all revenue comes from a single line: Services and other revenues.

That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.

Revenue last year:
$68.8M
The loss that same year:
$13.9M
For every $1 it earns, the company spends $1.2.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales are moving sideways.

No real growth (-1% a year). Red columns mark years that ended in a loss.

$72.5M
2021
2022
2023
2024
$68.8M
2025
In the vault right now:
$44.5M
DEBT: $542.8M
At this pace, that money lasts about 3.2 years.

At this burn rate the cash pile isn’t the pressing question — for now, time is on the company’s side.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
46
weak

Clearly below the class average.

FINANCIAL STRENGTH
80
very strong

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
14
very weak

Clearly below the class average.

GROWTH
76
strong

This grade is a blend: the profit side is strong, the sales tempo slow.

PRICE MOMENTUM
37
weak

Clearly below the class average.

WORTH WATCHING

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 87% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/1
Sales are holding up

The company sells $68.8M a year; the problem isn’t sales — it’s costs running above that number.

1
THE RISKS · 1/3
Running at a loss

A loss of $13.9M against $68.8M in annual sales.

2
THE RISKS · 2/3
The price runs ahead of the earnings

Today’s price already includes part of tomorrow’s optimism. Report-card grade: 14/100.

3
THE RISKS · 3/3
The stock has lost its spark

Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 37/100. For a turnaround signal, the stock first needs to close the gap with the market.

FINALE · THE GRADE
F
25 / 100 · MoonshotScore

On our five-subject report card, CCM sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: CCM is a small company that closed last year at a loss. The road back to profit runs through spending discipline.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film